Wayne Kaesemeyer

W H Kaesemeyer, MD is an independent research cardiologist whose current focus is preventing the activation of the NLRP3 inflammasome in the treatment of cardiovascular diseases, all as an extrapolation of his work on the cause and prevention of nitroglycerin tolerance. He has practiced for 28 years as a hypertension specialist who is board certified in internal medicine. This followed 4 years of medical school (MD 1978 Wake Forest University, Winston-Salem, NC) and 4 years of residency training that included a year as a chief resident, all of which followed initially working as a pharmaceutical chemist. He has been the principal investigator on 20 clinical trials of hypertension, lipids and heart failure medications. He is an author or co-author of over 35 publications and the inventor of 5 patents involving nitric oxide, nitroglycerin tolerance and statin nitric oxide pleiotropy.